To study outcomes in patients with non-thrombotic iliac vein lesions (NIVLs) treated by stents.
Methods
We performed a retrospective study that collected 109 patients from January 2016 to August 2020 diagnosed with symptomatic NIVLs. The patients underwent endovenous stenting using the Wallstents. Clinical severity was assessed using the venous clinical severity score and the Villalta scores. The patency was assessed using duplex ultrasound, while the diameters and the blood flow velocities (BFVs) in the proximal, middle, and distal stented segments were recorded simultaneously.
Results
A total of 128 stents were placed in 115 limbs (median age, 61 years), with a mean follow-up of 32 months. At 36 months, the Villalta scores went from 12.17 to 3.64 (p < .001). The VCSS went from 9.41 to 3.31 (p < .001). The mean diameters in the proximal, middle, and distal stented segments were 8.52 ± 2.15 mm, 10.13 ± 1.75 mm, and 10.17 ± 1.69 mm in the first month, while the mean BFVs were 31.17 ± 13.66 cm/s, 31.07 ± 11.90 cm/s, and 36.39 ± 18.41 cm/s, respectively. Repeated-measures analysis in 55 consecutive patients from 1 month to 3 years after procedure revealed a decrease of the stent diameter in the proximal stented segment (p = .004); a stabilization of the stent diameter in the middle (p = .43) or distal (p = .45) stented segment; a steadiness of the BFVs in the proximal (p = .40), middle (p = .93), and distal (p = .25) stented segments; and an improvement in the VCSS (p = .03) and Villalta scores (p = .006).
Conclusions
BFVs in stented segments remained steady and the symptoms in lower extremities improved after surgery, while stent compression was observed in the diameter of the proximal stented segment, with no impact on BFVs or symptoms.
MayRThurnerJ. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology1957; 8: 419–427.
2.
CockettFBThomasML. The iliac compression syndrome. Br J Surg1965; 52: 816–821.
3.
PatelKRRabinowitzDHastingsB, et al.Femorocaval bypass with femoral crossover bypass for iliofemoral and caval occlusion. J Vasc Surg1997; 26: 989–993.
4.
CasanegraAIMcBaneRDBjarnasonH. Intervention radiology for venous thrombosis: early thrombus removal using invasive methods. Br J Haematol2017; 177: 173–184. DOI: 10.1111/bjh.14581.
5.
AlhalbouniSDeemSAbu-HalimahS, et al.Atypical presentation of priapism in a patient with acute iliocaval deep venous thrombosis secondary to May-Thurner syndrome. Vasc Endovascular Surg2013; 47: 488–492. DOI: 10.1177/1538574413493680.
6.
GagnePJGagneNKucherT, et al.Long-term clinical outcomes and technical factors with the Wallstent for treatment of chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord2019; 7: 45–55. DOI: 10.1016/j.jvsv.2018.07.016.
7.
HagerESYuoTTaharaR, et al.Outcomes of endovascular intervention for May-Thurner syndrome. J Vasc Surg Venous Lymphat Disord2013; 1: 270–275. DOI: 10.1016/j.jvsv.2012.11.002.
8.
JayarajANoelCKuykendallR, et al.Long-term outcomes following use of a composite Wallstent-Z stent approach to iliofemoral venous stenting. J Vasc Surg Venous Lymphat Disord2021; 9: 393–400.e2. DOI: 10.1016/j.jvsv.2020.08.020.
9.
RizviSAAscherEHingoraniA, et al.Stent patency in patients with advanced chronic venous disease and nonthrombotic iliac vein lesions. J Vasc Surg Venous Lymphat Disord2018; 6: 457–463. DOI: 10.1016/j.jvsv.2018.02.004.
10.
RolloJCFarleySMOskowitzAZ, et al.Contemporary outcomes after venography-guided treatment of patients with May-Thurner syndrome. J Vasc Surg Venous Lymphat Disord2017; 5: 667–676.e1. DOI: 10.1016/j.jvsv.2017.02.009.
11.
RazaviMKJaffMRMillerLE. Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction: systematic review and meta-analysis. Circ Cardiovasc Interv2015; 8: e002772. DOI: 10.1161/CIRCINTERVENTIONS.115.002772.
12.
RajuSNeglenP. High prevalence of nonthrombotic iliac vein lesions in chronic venous disease: a permissive role in pathogenicity. J Vasc Surg2006; 44: 136–143. DOI: 10.1016/j.jvs.2006.02.065.
13.
PassmanMAMcLaffertyRBLentzMF, et al.Validation of Venous Clinical Severity Score (VCSS) with other venous severity assessment tools from the American Venous Forum, National Venous Screening Program. J Vasc Surg2011; 54: 2S–9S. DOI: 10.1016/j.jvs.2011.05.117.
14.
KahnSR. Measurement properties of the Villalta scale to define and classify the severity of the post-thrombotic syndrome. J Thromb Haemost2009; 7: 884–888. DOI: 10.1111/j.1538-7836.2009.03339.x.
15.
LaunoisRLe MoineJGLozanoFS, et al.Construction and international validation of CIVIQ-14 (a short form of CIVIQ-20), a new questionnaire with a stable factorial structure. Qual Life Res2012; 21: 1051–1058. DOI: 10.1007/s11136-011-0008-3.
16.
RutherfordRBBakerJDErnstC, et al.Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg1997; 26: 517–538.
17.
KibbeMRUjikiMGoodwinAL, et al.Iliac vein compression in an asymptomatic patient population. J Vasc Surg2004; 39: 937–943. DOI: 10.1016/j.jvs.2003.12.032.
18.
YeKLuXLiW, et al.Long-term outcomes of stent placement for symptomatic nonthrombotic iliac vein compression lesions in chronic venous disease. J Vasc Interv Radiol2012; 23: 497–502. DOI: 10.1016/j.jvir.2011.12.021.
19.
NeglénPRajuS. In-stent recurrent stenosis in stents placed in the lower extremity venous outflow tract. J Vasc Surg2004; 39: 181–187. DOI: 10.1016/s0741-5214(03)01028-0.
20.
ChoHKimJWHongYS, et al.Stent compression in iliac vein compression syndrome associated with acute ilio-femoral deep vein thrombosis. Korean J Radiol2015; 16: 723–728. DOI: 10.3348/kjr.2015.16.4.723.
21.
LiuHWangJZhaoY, et al.Doppler ultrasound and contrast-enhanced ultrasound in detection of stent stenosis after iliac vein stenting. BMC Cardiovasc Disord2021; 21: 42. DOI: 10.1186/s12872-020-01840-3.
22.
EspositoACharisisNKantarovskyA, et al.A Comprehensive review of the pathophysiology and clinical importance of iliac vein obstruction. Eur J Vasc Endovasc Surg2020; 60: 118–125. DOI: 10.1016/j.ejvs.2020.03.020.
23.
UsuiNMKYamamotoH. Ilium and femoral vein thrombosis. Surgery1978; 1978: 983.
24.
MitsuokaHOhtaTHayashiS, et al.Histological study on the left common iliac vein spur. Ann Vasc Dis2014; 7: 261–265. DOI: 10.3400/avd.oa.14-00082.
25.
JayarajAFullerRRajuS, et al.In-stent restenosis and stent compression following stenting for chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord2022; 10: 42–51. DOI: 10.1016/j.jvsv.2021.06.009.
26.
BadeshaASBainsPRSBainsBRS, et al.A systematic review and meta-analysis of the treatment of obstructive chronic deep venous disease using dedicated venous stents. J Vasc Surg Venous Lymphat Disord2022; 10: 267–282.e4. DOI: 10.1016/j.jvsv.2021.04.014.
27.
van VuurenTde WolfMAFArnoldussenC, et al.Editor’s Choice - Reconstruction of the femoro-ilio-caval outflow by percutaneous and hybrid interventions in symptomatic deep venous obstruction. Eur J Vasc Endovasc Surg2017; 54: 495–503. DOI: 10.1016/j.ejvs.2017.06.023.
28.
de WolfMAFde GraafRKurstjensRLM, et al.Short-term clinical experience with a dedicated venous nitinol stent: initial results with the sinus-venous stent. Eur J Vasc Endovasc Surg2015; 50: 518–526. DOI: 10.1016/j.ejvs.2015.05.011.
29.
JayarajAPowellTRajuS. Utility of the 50% stenosis criterion for patients undergoing stenting for chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord2021; 9: 1408–1415. DOI: 10.1016/j.jvsv.2021.05.008.
30.
JayarajABuckWKnightA, et al.Impact of degree of stenosis in May-Thurner syndrome on iliac vein stenting. J Vasc Surg Venous Lymphat Disord2019; 7: 195–202. DOI: 10.1016/j.jvsv.2018.10.001.
31.
TahaMAHBusuttilABootunR, et al.A clinical guide to deep venous stenting for chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord2022; 10: 258–266.e1. DOI: 10.1016/j.jvsv.2020.12.087.
SaleemTRajuS. An overview of in-stent restenosis in iliofemoral venous stents. J Vasc Surg Venous Lymphat Disord2022; 10: 492–503.e2. DOI: 10.1016/j.jvsv.2021.10.011.
34.
JalaieHArnoldussenCBarbatiM, et al.What predicts outcome after recanalization of chronic venous obstruction: hemodynamic factors, stent geometry, patient selection, anticoagulation or other factors?Phlebology2014; 29: 97–103. DOI: 10.1177/0268355514529510.
35.
MilinisKThaparAShalhoubJ, et al.Antithrombotic therapy following venous stenting: international delphi consensus. Eur J Vasc Endovasc Surg2018; 55: 537–544. DOI: 10.1016/j.ejvs.2018.01.007.
